invas
pulmonari
aspergillosi
ipa
common
complic
immunosuppress
rapid
diagnosi
use
molecular
techniqu
essenti
improv
patient
surviv
pcr
techniqu
promis
enhanc
aspergillu
detect
blood
respiratori
sampl
evalu
first
time
perform
two
commerci
realtim
pcr
kit
fumigatu
bioevolut
mycogeni
fumigatu
detect
fumigatu
dna
bronchoalveolar
lavag
bal
patient
without
ipa
seventythre
bal
sampl
includ
thirtyon
correspond
patient
probabl
ipa
patient
possibl
ipa
patient
without
aspergillosi
accord
european
organ
research
treatment
cancermycos
studi
group
criteria
probabl
ipa
group
fumigatu
bioevolut
mycogeni
fumigatu
realtim
pcr
kit
show
specif
sensit
respect
fumigatu
bioevolut
detect
aspergillu
dna
bal
sampl
posit
aspergillu
cultur
result
wherea
mycogeni
fumigatu
pcr
result
posit
possibl
ipa
group
posit
realtim
pcr
posit
aspergillu
cultur
result
patient
without
aspergillosi
posit
result
observ
realtim
pcr
kit
despit
presenc
variou
nonaspergillu
pathogen
group
studi
demonstr
excel
specif
good
sensit
fumigatu
dna
detect
bal
sampl
kit
invas
pulmonari
aspergillosi
ipa
common
complic
immunosuppress
particularli
deep
prolong
neutropenia
hematolog
malign
tumor
hematopoiet
stem
cell
transplant
hsct
solid
organ
transplant
major
risk
factor
ipa
follow
solid
tumor
multipl
immunosuppress
condit
aspergillu
fumigatu
frequent
speci
isol
aspergillosi
speci
aspergillu
flavu
aspergillu
niger
aspergillu
terreu
also
found
ipa
mortal
substanti
highest
hematolog
patient
hsct
studi
found
surviv
improv
patient
receiv
earli
appropri
antifung
therapi
rapid
accur
diagnosi
aspergillosi
essenti
initi
earli
treatment
ipa
diagnos
accord
clinic
radiolog
histolog
microbiolog
criteria
microbiolog
method
consist
direct
examin
cultur
respiratori
relev
sampl
fungal
antigen
detect
low
cultur
sensit
microbiolog
evid
aspergillu
presenc
difficult
establish
respiratori
sampl
antigen
detect
techniqu
improv
ipa
diagnosi
galactomannan
accur
marker
recommend
ipa
diagnosi
serum
commonli
use
bronchoalveolar
lavag
bal
fluid
index
threshold
recommend
manufactur
laboratori
use
higher
threshold
respiratori
sampl
improv
test
specif
variabl
result
explain
lack
standard
among
laboratori
galactomannan
detect
respiratori
sampl
serum
bdglucan
also
use
diagnosi
specif
aspergillu
pcr
techniqu
seem
promis
enhanc
aspergillu
detect
blood
respiratori
sampl
mani
inhous
pcr
test
develop
blood
respiratori
sampl
still
lack
standard
thu
need
standard
pcr
techniqu
better
ipa
diagnosi
commerci
realtim
pcr
kit
avail
detect
aspergillu
blood
respiratori
specimen
evalu
two
fumigatu
bioevolut
bioevolut
brysurmarn
franc
mycogeni
fumigatu
ademtech
pessac
franc
kit
never
compar
clinic
respiratori
sampl
studi
evalu
compar
routin
condit
perform
two
commerci
avail
pcr
kit
detect
fumigatu
dna
bal
sampl
patient
without
ipa
studi
conduct
retrospect
bal
sampl
address
microbiolog
laboratori
strasbourg
univers
hospit
februari
novemb
routin
mycolog
bacteriolog
virolog
examin
routin
mycolog
analysi
bal
sampl
consist
direct
examin
musto
stain
semiquantit
cultur
determin
galactomannan
index
platelia
aspergillu
antigen
biorad
schiltigheim
franc
pneumocysti
jirovecii
detect
pcr
semiquantit
cultur
realiz
follow
ml
bal
depend
initi
bal
volum
receiv
centrifug
minut
g
ml
pellet
cultiv
onto
chromid
candida
medium
pari
franc
incub
day
c
follow
day
c
morpholog
fumigatu
identif
confirm
btubulin
sequenc
comparison
genbank
centraalbureau
voor
schimmelcultur
cb
european
molecular
biolog
laboratori
databas
mean
inhibitori
concentr
mic
amphotericin
b
caspofungin
fluconazol
voriconazol
posaconazol
determin
etest
determin
galactomannan
index
platelia
aspergillu
antigen
biorad
perform
bal
supernat
concomit
serum
sampl
dna
p
jirovecii
detect
obtain
use
manual
extract
kit
qiaamp
dna
mini
kit
qiagen
courtaboeuf
franc
retrospect
studi
dna
previous
extract
bal
routin
p
jirovecii
pcr
use
dna
extract
use
extract
kit
qiaamp
dna
mini
kit
qiagen
avail
dnarna
extract
variabl
bal
sampl
volum
ml
depend
initi
sampl
volum
receiv
centrifug
ml
pellet
extract
accord
manufactur
recommend
ml
elut
volum
posit
neg
extract
control
use
extract
run
check
p
jirovecii
pcr
dna
store
c
one
freezingthaw
cycl
aspergillu
dna
detect
use
two
commerci
realtim
pcr
kit
fumigatu
bioevolut
kit
mycogeni
fumigatu
kit
fumigatu
bioevolut
pcr
kit
target
region
allow
specif
detect
fumigatu
dna
limit
detect
lod
copiesml
valid
serum
sinu
biopsi
specimen
realtim
pcr
perform
accord
manufactur
instruct
ml
dna
extract
kit
inhibit
control
amplifi
lightcycl
roch
meylan
franc
quantit
cycl
consid
posit
posit
control
use
quantifi
dna
provid
kit
mycogeni
fumigatu
multiplex
kit
detect
rrna
fumigatu
lod
copyml
major
azol
resist
mutat
lod
copiesml
valid
respiratori
tract
biopsi
serum
sampl
realtim
pcr
perform
accord
manufactur
instruct
use
ml
dna
extract
kit
inhibit
control
amplifi
lightcycl
roch
meylan
franc
posit
control
fumigatu
sensu
stricto
cultur
use
quantit
cycl
consid
posit
fumigatu
detect
mutat
detect
bal
sampl
follow
data
record
age
sex
patient
underli
condit
presenc
durat
antifung
therapi
bal
test
mycolog
result
direct
examin
bal
cultur
isol
aspergillu
respiratori
specimen
episod
bal
galactomannan
index
threshold
accord
manufactur
recommend
sera
galactomannan
index
pathogen
recov
bal
episod
episod
classifi
probabl
ipa
possibl
ipa
nonipa
episod
accord
european
organ
research
treatment
cancermycos
studi
group
journal
molecular
diagnosticsjmdamjpatholorg
eortcmsg
criteria
exclud
pcr
patient
cancer
sever
neutropenia
hsct
solid
organ
transplant
tcell
immunosuppress
steroid
treatment
patient
lack
underli
condit
specif
algorithm
develop
intens
care
unit
patient
appli
kit
clinic
sensit
specif
calcul
accord
final
diagnosi
provenprob
ipa
clinic
sensit
nonparametr
binomi
mcnemar
test
use
statist
analysi
seventythre
bal
sampl
includ
studi
thirtyon
correspond
probabl
ipa
possibl
ipa
nonaspergillosi
pulmonari
episod
accord
eortcmsg
criteria
without
consid
aspergillu
pcr
result
proven
ipa
diagnos
studi
demograph
underli
condit
data
present
tabl
detail
microbiolog
galactomannan
result
tabl
underli
condit
hematolog
malign
tumor
n
z
solid
organ
transplant
n
z
allogen
bone
marrow
transplant
n
z
solid
tumor
n
z
condit
n
z
neutropenia
report
patient
patient
present
clinic
criteria
ipa
dens
wellcircumscrib
nodul
without
halo
sign
pulmonari
condens
fifteen
patient
receiv
antiaspergillu
antifung
treatment
time
bal
sampl
mean
durat
day
rang
day
bal
fourteen
bal
test
posit
fumigatu
sensu
stricto
cultur
semiquantit
count
vari
coloni
bal
test
posit
aspergillu
galactomannan
fumigatu
bioevolut
kit
clinic
sensit
specif
posit
bal
result
respect
final
diagnosi
document
pulmonari
infect
attribut
anoth
pathogen
patient
three
bacteri
infect
two
viral
infect
five
p
jirovecii
pneumonia
one
mucormycosi
one
cryptococcosi
one
pulmonari
dissemin
toxoplasmosi
one
p
jirovecii
cytomegaloviru
coinfect
noninfecti
pulmonari
diseas
two
patient
routin
control
bal
lung
transplant
patient
posit
result
observ
either
two
pcr
kit
despit
presenc
variou
pathogen
group
specif
kit
studi
evalu
two
commerci
avail
realtim
pcr
kit
fumigatu
dna
detect
retrospect
bal
sampl
patient
probabl
ipa
patient
possibl
ipa
patient
without
aspergillosi
studi
popul
display
risk
factor
usual
found
individu
probabl
possibl
ipa
hematolog
malign
tumor
neutropenia
solid
organ
transplant
allogen
bone
marrow
transplant
immunosuppress
therapi
termin
organ
failur
two
evalu
kit
show
excel
specif
kit
crossreact
pathogen
test
good
clinic
sensit
probabl
ipa
signific
differ
two
kit
journal
molecular
diagnosticsjmdamjpatholorg
fumigatu
bioevolut
versu
mycogeni
p
z
three
bal
result
discord
two
pcr
kit
three
bal
sampl
posit
galactomannan
index
two
posit
fumigatu
cultur
result
one
six
coloni
none
patient
discord
bal
result
receiv
previou
antifung
therapi
two
sampl
posit
cultur
detect
mycogeni
kit
despit
use
larger
extract
volum
display
lower
lod
lod
determin
manufactur
mycogeni
fumigatu
dna
extract
reagent
use
manual
qiagen
extract
could
explain
decreas
analyt
sensit
requir
reevalu
lod
sever
studi
test
inhous
pcr
commerci
pcr
kit
respiratori
sampl
clinic
sensit
inhous
pcr
vari
among
studi
accord
patient
popul
mani
pcr
kit
commerci
detect
aspergillu
aspergeniu
mycassay
fumigatu
genesig
fungiplex
renishaw
etc
test
respiratori
sampl
bal
bronchial
lavag
sputum
patient
risk
aspergillosi
studi
use
aspergeniu
kit
show
sensit
specif
crossreact
rhizopu
oryza
penicillium
chrysogenum
mycassay
aspergillu
kit
variou
sensit
specif
crossreact
flavu
mycogeni
fumigatu
studi
show
sensit
versu
cultur
specif
variat
sensit
may
explain
variou
pcr
target
includ
rrna
aspergeniu
mycogeni
rrna
mycassay
fumigatu
bioevolut
well
differ
method
dna
extract
although
wheat
et
al
describ
equival
perform
manual
autom
dna
extract
process
better
sensit
observ
other
autom
extract
multicent
analysi
white
et
al
demonstr
better
pcr
sensit
use
larger
sampl
volum
small
elut
volum
ml
studi
dna
previous
manual
extract
p
jirovecii
routin
pcr
kit
evalu
routin
condit
balextract
volum
depend
volum
initi
sampl
receiv
vari
ml
studi
show
equival
effici
pellet
supernat
extract
fumigatu
detect
wherea
other
reveal
better
effici
extract
use
pellet
bal
concentr
centrifug
ml
pellet
extract
recommend
extract
kit
manufactur
elut
volum
use
extract
process
ml
accord
routin
extract
protocol
optim
elut
volum
ml
may
improv
detect
capac
test
pcr
previou
antifung
therapi
may
affect
pcr
sensit
result
studi
result
controversi
author
show
effect
prior
antifung
treatment
wherea
other
observ
decreas
pcr
sensit
previou
antifung
treatment
significantli
alter
pcr
result
could
explain
neg
pcr
probabl
ipa
group
fumigatu
bioevolut
mycogeni
fumigatu
kit
increas
fumigatu
detect
bal
show
higher
clinic
sensit
cultur
bal
posit
pcr
neg
cultur
result
respect
higher
sensit
detect
aspergillu
respiratori
sampl
allow
upgrad
possibl
ipa
probabl
ipa
studi
pcr
posit
possibl
ipa
group
low
fungal
load
could
explain
poor
detect
fumigatu
possibl
ipa
despit
low
limit
detect
way
enhanc
detect
sensit
group
would
analyz
multipl
respiratori
bal
serum
sampl
patient
two
kit
allow
identif
fumigatu
sensu
lato
unlik
commerci
kit
detect
aspergillu
speci
sever
speci
genu
aspergillu
aspergeniu
mycassay
fumigatu
sensu
lato
repres
ipa
detect
essenti
ipa
diagnosi
thu
lack
detect
aspergillu
speci
could
problemat
fumigatu
cryptic
speci
isol
studi
thu
detect
fumigatu
cryptic
speci
could
studi
howev
extens
studi
evalu
detect
cryptic
fumigatu
speci
would
valuabl
nevertheless
identif
aspergillu
speci
speci
level
case
neg
bal
cultur
result
improv
diagnosi
accuraci
could
allow
quick
adjust
antifung
therapi
especi
nonaspergillu
infect
suspect
mycogeni
fumigatu
kit
also
allow
detect
major
azol
resist
mutat
increas
azol
fumigatu
resist
europ
recent
report
detect
azol
resist
mutat
pcr
interest
appropri
treatment
particularli
strain
isol
studi
mutat
detect
confirm
mic
previous
determin
etest
consist
first
mycogeni
fumigatu
studi
rare
case
azoleresist
strain
isol
eastern
franc
allow
us
use
mic
determin
test
sensit
mani
azol
drug
amphotericin
b
aspergillu
dna
detect
bal
fluid
promis
tool
ipa
diagnosi
studi
two
pcr
kit
confirm
fumigatu
dna
presenc
nine
bal
sampl
neg
cultur
result
posit
galactomannan
index
among
two
bal
galactomannan
index
two
index
galactomannan
posit
threshold
still
controversi
bal
studi
posit
galactomannan
index
threshold
use
accord
manufactur
recommend
author
use
galactomannan
indexex
realtim
pcr
aspergillu
bal
journal
molecular
diagnosticsjmdamjpatholorg
pcr
would
particularli
help
confirm
aspergillu
presenc
moreov
pcr
would
interest
patient
neg
cultur
result
galactomannan
index
bal
serum
galactomannan
index
confirm
presenc
pulmonari
aspergillu
aspergillu
dna
detect
ipa
diagnosi
sever
type
sampl
use
metaanalysi
inhous
pcr
commerci
kit
use
blood
sampl
plasma
sera
show
mean
sensit
specif
ipa
diagnosi
anoth
metaanalysi
compar
aspergillu
pcr
bal
serum
sampl
obtain
lower
sensit
bal
compar
serum
versu
respect
higher
specif
bal
versu
serum
patient
ipa
two
type
sampl
seem
complementari
ipa
diagnosi
sever
studi
propos
serum
dna
detect
noninvas
screen
techniqu
popul
risk
ipa
feasibl
specif
bal
fluid
difficult
obtain
thu
could
use
confirm
aspergillu
presenc
enhanc
sensit
aspergillu
detect
respiratori
sampl
howev
aspergillu
dna
detect
bal
differenti
colon
invas
pulmonari
infect
allerg
aspergillosi
cultur
galactomannan
remain
detect
method
aspergillu
presenc
improv
ipa
diagnosi
standard
valid
molecular
techniqu
requir
studi
demonstr
excel
specif
good
sensit
fumigatu
dna
detect
bal
sampl
fumigatu
bioevolut
mycogeni
fumigatu
kit
studi
increas
number
ipa
greater
rang
speci
would
valuabl
